Clin Osteol 2009; 14(2): 39-40

Current pediatric osteologyReview articles

M. Bayer

Published: December 11, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bayer M. Current pediatric osteology. Osteologický bulletin. 2009;14(2):39-40.
Download citation

References

  1. Rauch F., Plotkin H, DiMeglio L, et al. Fracture prediction and the definition of osteoporosis in children and adolescents: The ISCD 2007 Pediatric Official Positions. J Clin Densitometry 2008;11:22-28. Go to original source...
  2. Seeman E. Is a change in bone mineral density a sensitive and specific surrogate of anti-fracture efficacy? Bone 2007;41:308-317. Go to original source...
  3. Bain S, Leonard MB, Bianchi M-L, et al. Official positions of the International Society for Clinical Densitometry and Executive Summary of the 2007 ISCD Pediatric Position Development Conference. J Clin Densitometry 2008; 11:6-21. Go to original source...
  4. Kelly TL, Specker BL, Binkley T, et al. Pediatric BMD reference database for US white children. Bone 2005;36(Suppl.1):S30.
  5. Crabtree NJ, Oldroyal B, Truscott JG, et al. UK pediatric DXA reference data (GE Lunar Prodigy): effects of ethnicity, gender, and pubertal status. Bone 2005; 36(Suppl.1):S42.
  6. Kalkwarf JH, Zemel BS, Gilsanz V, et al. The bone mineral density in childhood study: Bone mineral content and density according to age, sex, and race. J Clin Endocrinol Metab 2007;92:2087-2099. Go to original source...
  7. Wetzsteon RJ, Hughes JM, Kaufman BC, et al. Ethnic differences in bone geo­ metry and strength are apparent in childhood. Bone 2009;44(5):970-975. Go to original source...
  8. Flynn J, Foley S, Jones G. Can BMD assessed by DXA at age 8 predict fracture risk in boys and girls during puberty?: An eight-year prospective study. J Bone Miner Res 2007;22:1463-1467. Go to original source...
  9. Moyer-Mileur LJ, Quick JL, Murray MA Peripheral quantitative computed tomo­ graphy of the tibia: pediatric reference values. J Clin Densitometry 2008;11: 283-294. Go to original source...
  10. Šumník Z, Souček O. Diagnostika osteoporózy v dětském věku. Osteol Bull 2009;14(2):41-49.
  11. Baroncelli GI. Quantitative ultrasound methods to assess bone mineral status in children:technical characteristics, performance, and clinical application. Pediatr Res 2008; 63(3):220-228. Go to original source...
  12. Rauchenzauner M, Schmid A, Heinz-Erian P, et al. Sex- and age-specific referen­ ce curves for serum markers of bone turnover in healthy children from 2 months to 18 years. J Clin Endocrinol Metab 2007;92(2):443^49. Go to original source...
  13. Munns CF, Rauch F, Travers R, Glorieux FH. Effects of intravenous pamidronate treatment in infants with osteogenesis imperfecta: clinical and histomorphometric outcome. J Bone Miner Res 2005;20(7):1235-1243 Go to original source...
  14. Rauch F, Travers R, Glorieux FH. J^midronate in children with osteogenesis im­ perfecta: histomorphometric effects of long-term therapy. J Clin Endocrinol Metab 2006;91(2):511-516. Go to original source...
  15. Bayer M. Osteogenesis imperfecta u dětí - co by měli vědět ošetřující lékaři. Osteol Bull 2009;14(2):49-57.
  16. Ward L, Tricco AC, Phuong P, et al. Bisphosphonate therapy for children and ado­ lescents with secondary osteoporosis. Cochrane Database Syst Rev 2007;(4): CD005324. Go to original source...
  17. Feber J, Geier P. Poruchy kostního metabolizmu u dětí s nefrotickým syndromem. Osteol Bull 2009;14(2):59-63.
  18. Skálová S, Kutílek Š. Hyperkalciurie v dětském věku. Osteol Bull 2009;14(2): 63-70.




Clinical Osteology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.